Does coronary Atherosclerosis Deserve to be Diagnosed earlY in Diabetic patients? The DADDY-D trial. Screening diabetic patients for unknown coronary disease


      • Silent myocardial ischemia involve a high risk of cardiac events
      • Among diabetic patients no benefit derived from screening and treatment of silent myocardial ischemia
      • This topic however, deserve deeper investigation rethinking more appropriate end points and selection criteria



      To evaluate if screening and treatment of asymptomatic coronary artery disease (CAD) are effective in preventing first cardiac event in diabetics.


      Diabetic patients without known CAD were randomly assigned to undergo a screening for silent myocardial ischemia followed by revascularization or to continue follow-up.
      The reduction of cardiac death (CD) or nonfatal myocardial infarction (MI) represented the primary aim; secondary aim was the prevention of heart failure (HF).


      From September 2007 to May 2012, 520 patients (62 years; 104 female) were enrolled. Silent CAD was found in 20 of 262 patients (7.6%), revascularization was performed in 12 (4.6%).
      After a mean follow-up of 3.6 years 12 events (4.6%) occurred in the study group and 14 (5.4%) in the follow-up (HR = 0.849, 95% CI: 0.393–1.827, P = 0.678). The occurrence of first HF episode did not differ between groups: 2 (0.8%) in screened and 7 (2.7%) in follow-up (HR = 0.273, 95% CI: 0.057–1.314, P = 0.083).
      Subgroup analysis revealed a significantly lower HF episodes among patients with intermediate cardiovascular risk (Log rank P = 0.022). Additionally, when CD and MI were analysed within subgroups, a significant lower number of CDs was observed among older than 60 years (P = 0.044).


      Screening and revascularization of silent CAD in diabetics, failed to demonstrate a significant reduction in cardiac events and HF episodes. However, our data indicate that further research is warranted in patients older than 60 years and those with an intermediate cardiovascular risk.



      CAD (Coronary artery disease), ETT (Exercise tolerance testing), CV (Cardiovascular), HF (Heart failure), MI (Myocardial infarction)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Morrish N.J.
        • Wang S.L.
        • Stevens L.K.
        • Fuller J.H.
        • Keen H.
        Mortality and causes of death in the WHO Multinational Study of vascular diseases in diabetes.
        Diabetologia. 2001; 44: S14-S21
        • Jacoby R.M.
        • Nesto R.W.
        Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis.
        J Am Coll Cardiol. 1992; 20: 736-744
        • Fazzini P.F.
        • Prati P.L.
        • Rovelli F.
        • Antoniucci D.
        • Menghini F.
        • Seccareccia F.
        • et al.
        Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project).
        Am J Cardiol. 1993; 72: 1383-1388
        • Cohn P.F.
        Silent myocardial ischemia: classification, prevalence, and prognosis.
        Am J Med. 1985; 79: 2-6
        • Bacci S.
        • Villella M.
        • Villella A.
        • Langialonga T.
        • Grilli M.
        • Rauseo A.
        • et al.
        Screening for silent myocardial ischemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test.
        Eur J Endocrinol. 2002; 147: 649-654
        • De Lorenzo A.
        • Lima R.S.
        • Siqueira-Filho A.G.
        • Pantoja M.R.
        Prevalence and prognostic value of perfusion defects detected by stress technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.
        Am J Cardiol. 2002; 90: 827-832
        • Miller T.D.
        • Rajagopalan N.
        • Hodge D.O.
        • Frye R.L.
        • Gibbons R.J.
        Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes.
        Am Heart J. 2004; 147: 890-896
        • Gazzaruso C.
        • Coppola A.
        • Montalcini T.
        • Valenti C.
        • Pelissero G.
        • Solerte S.B.
        • et al.
        Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients.
        Intern Emerg Med. 2012; 7: 257-266
        • Moret M.
        • Moulin P.
        Screening of silent myocardial ischemia in diabetic patients: practical details and issues.
        Presse Med. 2011; 40: 625-633
        • Turrini F.
        • Messora R.
        • Giovanardi P.
        • Tondi S.
        • Magnavacchi P.
        • Cavani R.
        • et al.
        Screening asymptomatic patients with diabetes for unknown coronary artery disease: does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D Trial (Does coronary Atherosclerosis Deserve to be Diagnosed and treated early in Diabetics?).
        Trials. 2009; 10: 119
      1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
        Diabetes Care. 1997; 20: 1183-1197
      2. Il progetto cuore: calcolo del punteggio individuale.
        ([2 September 2014])
        • Levey A.S.
        • Bosch J.P.
        • Lewis J.B.
        • Greene T.
        • Rogers N.
        • Roth D.
        A more accurate accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.
        Ann Intern Med. 1999; 130: 461-470
        • Ryden L.
        • Standl E.
        • Bartnik M.
        • Van den Berghe G.
        • Betteridge J.
        • de Boer M.J.
        • et al.
        Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
        Eur Heart J. 2007; 28: 88-136
        • Gibbons R.J.
        • Balady G.J.
        • Bricker J.T.
        • Chaitman B.R.
        • Fletcher G.F.
        • Froelicher V.F.
        • et al.
        Committee to Update the 1997 Exercise Testing Guidelines. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).
        J Am Coll Cardiol. 2002; 40: 1531-1540
        • Gulati M.
        • Black H.R.
        • Shaw L.J.
        • Arnsdorf M.F.
        • Merz C.N.
        • Lauer M.S.
        • et al.
        The prognostic value for exercise capacity in woman.
        N Engl J Med. 2005; 353: 468-475
        • Avogaro A.
        • Giorda C.
        • Maggini M.
        • Mannucci E.
        • Raschetti R.
        • Lombardo F.
        • et al.
        Incidence of coronary heart disease in type 2 diabetic men and women.
        Diabetes Care. 2007; 30: 1241-1247
        • Bourassa M.G.
        • Knatterud G.L.
        • Pepine C.J.
        • Sopko G.
        • Rogers W.J.
        • Geller N.L.
        • et al.
        Asymptomatic cardiac ischemia pilot (ACIP) study—improvement of cardiac ischemia at 1 year after PTCA and CABG.
        Circulation. 1995; 92: 1-7
        • Faglia E.
        • Favales F.
        • Calia P.
        • Paleari F.
        • Segalini G.
        • Gamba P.L.
        • et al.
        Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown coronary heart disease.
        Diabetes Care. 2002; 25: 2032-2036
        • Wittes J.
        Sample size calculations for randomized controlled trials.
        Epidemiol Rev. 2002; 24: 39-53
        • Faglia E.
        • Manuela M.
        • Antonella Q.
        • Michela G.
        • Vincenzo C.
        • Maurizio C.
        • et al.
        Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study.
        Am Heart J. 2005; 149: e1-e6
        • Young L.H.
        • Wackers F.J.
        • Chyun D.A.
        • Davey J.A.
        • Barrett E.J.
        • Taillefer R.
        • et al.
        Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.
        JAMA. 2009; 301: 1547-1555
        • Grimes D.A.
        • Schultz K.F.
        Uses and abuses of screening tests.
        Lancet. 2002; 359: 881-884
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • et al.
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Frye R.L.
        • August P.
        • Brooks M.M.
        • Hardison R.M.
        • Kelsey S.F.
        • MacGregor J.M.
        • et al.
        BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease.
        N Engl J Med. 2009; 360: 2503-2515
        • American Diabetes Association
        Standards of medical care in diabetes—2014.
        Diabetes Care. 2014; 37: S14-S80
        • UK Colorectal Cancer Screening Pilot Group
        Results of the first round of a demonstration pilot of screening for colorectal cancer in the United kingdom.
        BMJ. 2004; 329: 133
        • Smith-Bindman R.
        • Chu P.W.
        • Miglioretti D.L.
        • Sickles E.A.
        • Blanks R.
        • Ballard-Barbash R.
        • et al.
        Comparison of screening mammography in the United States and the United kingdom.
        JAMA. 2003; 290: 2129-2137
      3. Ischemia study.
        ([2 September 2014])
        • Kuller L.H.
        Does the Framingham risk score predict risk in women as well as it does in men?.
        Curr Cardiol Risk Rep. 2010; 4: 229-236
        • Tavel M.E.
        Stress testing in cardiac evaluation current concepts with emphasis on the ECG.
        Chest. 2001; 119: 907-925
        • Michealides A.P.
        • Psomadaki Z.D.
        • Dilaveris P.E.
        • Andrikopoulos G.K.
        • Aggeli K.D.
        • Stefanidis C.I.
        • et al.
        Improved detection of coronary artery disease by exercise eletrocardiography with the use of right precordial leads.
        N Engl J Med. 1999; 340: 340-345